Long-term Opioid Therapy, Misuse and Mortality in Patients With Chronic Non-cancer Pain in Germany

CompletedOBSERVATIONAL
Enrollment

3,232

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Pain
Interventions
DRUG

Analgesics, Opioid

"Patients are included in the long-term opioid group if they started an opioid-therapy between 2013 and 2017 and received consecutive prescriptions for opioid medications over a minimum of 3 quarters, over a 60-month period between January 1, 2013, and December 31, 2017. The treatment will be assessed using the ATC codes of opioid~treatment N02AA01, N02AA05, N02AB03, N02AE01, N02AX02, N02AX01, N02AX06) reported in reimbursed medicines to patients."

DRUG

Non-Opioid Analgesic

Patients with non-opioid pain medication are included, if they received a medication therapy with anticonvulsants (gabapentin, pregabalin, carbamazepine), antidepressants or non-opioid analgesics (NSAIDs, Metamizole) over a minimum of 3 quarters, over a 60-month period between January 1, 2013, and December 31, 2017. The non-opioid treatment will be assessed using the ATC codes (N03AX12, N03AX16, N03AF01) of treatment reported in reimbursed medicines to patients.

Trial Locations (1)

70469

LinkCare GmbH, Stuttgart

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Grünenthal GmbH

INDUSTRY

collaborator

Klinikum Saarbrücken

UNKNOWN

collaborator

Ruhr University of Bochum

OTHER

collaborator

Technical University of Munich

OTHER

lead

LinkCare GmbH

INDUSTRY